Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Reply to: economic evaluation of second generation pneumococcal conjugate vaccines in Norway.

Farkouh R, Klok R, Roberts C, Mack A, Strutton D.

Vaccine. 2013 Jan 7;31(3):439-41. doi: 10.1016/j.vaccine.2012.03.012. Epub 2012 Mar 17. No abstract available.

PMID:
22433959
2.

Response to "reply to: economic evaluation of second generation pneumococcal conjugate vaccines in Norway".

Robberstad B, Akselsen PE, Kværner KJ, Berstad AK.

Vaccine. 2013 Jan 7;31(3):442-3. doi: 10.1016/j.vaccine.2012.11.050. Epub 2012 Nov 29. No abstract available.

PMID:
23200941
3.

Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.

Robberstad B, Frostad CR, Akselsen PE, Kværner KJ, Berstad AK.

Vaccine. 2011 Nov 3;29(47):8564-74. doi: 10.1016/j.vaccine.2011.09.025. Epub 2011 Sep 21.

PMID:
21945264
4.

Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine.

Prosser LA, Ray GT, O'Brien M, Kleinman K, Santoli J, Lieu TA.

Pediatrics. 2004 Feb;113(2):283-90.

PMID:
14754939
5.

[Medical indications and effectiveness of the pneumococcal conjugate vaccine].

Reinert RR.

Laryngorhinootologie. 2006 Apr;85(4):291-8; quiz 299-300. German.

PMID:
16615030
6.

The cost-effectiveness of pneumococcal conjugate vaccination in Australia.

Butler JR, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B.

Vaccine. 2004 Mar 12;22(9-10):1138-49.

PMID:
15003641
7.

Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines.

Chuck AW, Jacobs P, Tyrrell G, Kellner JD.

Vaccine. 2010 Jul 26;28(33):5485-90. doi: 10.1016/j.vaccine.2010.05.058. Epub 2010 Jun 8.

PMID:
20554066
8.

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland.

Blank PR, Szucs TD.

Vaccine. 2012 Jun 13;30(28):4267-75. doi: 10.1016/j.vaccine.2012.04.028. Epub 2012 Apr 20.

9.

[Value of pneumococcal vaccination in infants and young children].

Adam D, Scholz H.

Klin Padiatr. 2001 May-Jun;213(3):109-13. German.

PMID:
11417363
10.

A pneumococcal conjugate vaccine for infants and children.

[No authors listed]

Med Lett Drugs Ther. 2000 Mar 20;42(1074):25-7. No abstract available.

PMID:
10776409
11.

Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.

Rückinger S, van der Linden M, Siedler A, von Kries R.

Klin Padiatr. 2011 Mar;223(2):61-4. doi: 10.1055/s-0030-1268465. Epub 2011 Jan 26.

PMID:
21271500
12.

The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.

Silfverdal SA, Berg S, Hemlin C, Jokinen I.

Vaccine. 2009 Mar 4;27(10):1601-8. doi: 10.1016/j.vaccine.2008.12.033. Epub 2009 Jan 13.

PMID:
19146905
13.

Pneumococcal conjugate vaccines: epidemiology guides clinical use.

Heininger U.

Klin Padiatr. 2011 Mar;223(2):59-60. doi: 10.1055/s-0031-1271765. Epub 2011 Mar 23. No abstract available.

PMID:
21432762
14.

[Therapeutic approaches in children immunized with vaccine Prevenar].

Cohen R, Aujard Y, Bingen E, Boucherat M, Bourrillon A, Foucaud P, Francois M, Garnier JM, Guillot M, Ovetchkine P, Ployet MJ, Quinet B, Gaudelus J.

Arch Pediatr. 2002 Jan;9(1):4-6. French. No abstract available.

PMID:
11865548
16.

[Pneumococcal infections. New vaccine protects even young children].

Meissner T.

MMW Fortschr Med. 2001 Jul 19;143(28-29):17. German. No abstract available.

PMID:
11499141
17.

Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.

Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.

Pediatrics. 2009 Jun;123(6):e1103-10. doi: 10.1542/peds.2008-3422.

PMID:
19482744
18.

Pneumococcal vaccines: present and future.

Peters TR, Edwards KM.

Pediatr Ann. 2002 Apr;31(4):261-8. Review. No abstract available.

PMID:
11966249
19.

New vaccines against otitis media: projected benefits and cost-effectiveness.

O'Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA.

Pediatrics. 2009 Jun;123(6):1452-63. doi: 10.1542/peds.2008-1482.

PMID:
19482754
20.

Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.

De Wals P, Black S, Borrow R, Pearce D.

Clin Ther. 2009 Oct;31(10):2152-69. doi: 10.1016/j.clinthera.2009.10.014.

PMID:
19922887

Supplemental Content

Support Center